| Dr Jeffrey David Crawford, MD | |
|
3615 Nw Samaritan Dr Ste 201, Corvallis, OR 97330-3771 | |
| (541) 768-5930 | |
| Not Available |
| Full Name | Dr Jeffrey David Crawford |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 13 Years |
| Location | 3615 Nw Samaritan Dr Ste 201, Corvallis, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003106071 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | MD167580 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Legacy Emanuel Medical Center | Portland, OR | Hospital |
| Legacy Good Samaritan Medical Center | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Good Samaritan Hospital Corvallis | 1557270725 | 339 |
| Legacy Clinics Llc | 0244144004 | 603 |
| Peacehealth Medical Group | 9032023270 | 206 |
News Archive
A growing cadre of specialists - geriatric oncologists - is the latest group of medical pioneers to meet the challenge of a rising cancer incidence among older adults. They are investigating how to fill the gaps in the way oncology is practiced today, which sometimes neglects the special needs of the elderly.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announced today that it conducted its first clinical Investigators Meeting for Oregovomab in Rome, Italy.
The world is bracing for the impact of the novel coronavirus, COVID-19, which has now spread to over 30 countries, infecting more than 80,000 people with over 2,600 deaths globally. A better understanding of how this virus is transmitted is key to preventing its spread.
STAQ (Safety, Transparency, Availability, Quality) Pharma and Children's Hospital Colorado (Children's Colorado) announced today the completion of product development work and the launch of several important sterile compounded medications that are widely used in pediatric hospitals.
According to US researchers, data on drugs that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines hit the market. They released a study this Tuesday in Journal of the American Medical Association which found nearly a third of new drug approvals from the Food and Drug Administration included no data on how well the medications compare with existing alternatives.
› Verified 6 days ago
| Entity Name | Peacehealth Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447207287 PECOS PAC ID: 9032023270 Enrollment ID: O20031113000097 |
News Archive
A growing cadre of specialists - geriatric oncologists - is the latest group of medical pioneers to meet the challenge of a rising cancer incidence among older adults. They are investigating how to fill the gaps in the way oncology is practiced today, which sometimes neglects the special needs of the elderly.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announced today that it conducted its first clinical Investigators Meeting for Oregovomab in Rome, Italy.
The world is bracing for the impact of the novel coronavirus, COVID-19, which has now spread to over 30 countries, infecting more than 80,000 people with over 2,600 deaths globally. A better understanding of how this virus is transmitted is key to preventing its spread.
STAQ (Safety, Transparency, Availability, Quality) Pharma and Children's Hospital Colorado (Children's Colorado) announced today the completion of product development work and the launch of several important sterile compounded medications that are widely used in pediatric hospitals.
According to US researchers, data on drugs that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines hit the market. They released a study this Tuesday in Journal of the American Medical Association which found nearly a third of new drug approvals from the Food and Drug Administration included no data on how well the medications compare with existing alternatives.
› Verified 6 days ago
| Entity Name | Legacy Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902827272 PECOS PAC ID: 0244144004 Enrollment ID: O20031117000089 |
News Archive
A growing cadre of specialists - geriatric oncologists - is the latest group of medical pioneers to meet the challenge of a rising cancer incidence among older adults. They are investigating how to fill the gaps in the way oncology is practiced today, which sometimes neglects the special needs of the elderly.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announced today that it conducted its first clinical Investigators Meeting for Oregovomab in Rome, Italy.
The world is bracing for the impact of the novel coronavirus, COVID-19, which has now spread to over 30 countries, infecting more than 80,000 people with over 2,600 deaths globally. A better understanding of how this virus is transmitted is key to preventing its spread.
STAQ (Safety, Transparency, Availability, Quality) Pharma and Children's Hospital Colorado (Children's Colorado) announced today the completion of product development work and the launch of several important sterile compounded medications that are widely used in pediatric hospitals.
According to US researchers, data on drugs that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines hit the market. They released a study this Tuesday in Journal of the American Medical Association which found nearly a third of new drug approvals from the Food and Drug Administration included no data on how well the medications compare with existing alternatives.
› Verified 6 days ago
| Entity Name | Good Samaritan Hospital Corvallis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962453134 PECOS PAC ID: 1557270725 Enrollment ID: O20031125000163 |
News Archive
A growing cadre of specialists - geriatric oncologists - is the latest group of medical pioneers to meet the challenge of a rising cancer incidence among older adults. They are investigating how to fill the gaps in the way oncology is practiced today, which sometimes neglects the special needs of the elderly.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announced today that it conducted its first clinical Investigators Meeting for Oregovomab in Rome, Italy.
The world is bracing for the impact of the novel coronavirus, COVID-19, which has now spread to over 30 countries, infecting more than 80,000 people with over 2,600 deaths globally. A better understanding of how this virus is transmitted is key to preventing its spread.
STAQ (Safety, Transparency, Availability, Quality) Pharma and Children's Hospital Colorado (Children's Colorado) announced today the completion of product development work and the launch of several important sterile compounded medications that are widely used in pediatric hospitals.
According to US researchers, data on drugs that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines hit the market. They released a study this Tuesday in Journal of the American Medical Association which found nearly a third of new drug approvals from the Food and Drug Administration included no data on how well the medications compare with existing alternatives.
› Verified 6 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740223874 PECOS PAC ID: 8527016039 Enrollment ID: O20050111000353 |
News Archive
A growing cadre of specialists - geriatric oncologists - is the latest group of medical pioneers to meet the challenge of a rising cancer incidence among older adults. They are investigating how to fill the gaps in the way oncology is practiced today, which sometimes neglects the special needs of the elderly.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announced today that it conducted its first clinical Investigators Meeting for Oregovomab in Rome, Italy.
The world is bracing for the impact of the novel coronavirus, COVID-19, which has now spread to over 30 countries, infecting more than 80,000 people with over 2,600 deaths globally. A better understanding of how this virus is transmitted is key to preventing its spread.
STAQ (Safety, Transparency, Availability, Quality) Pharma and Children's Hospital Colorado (Children's Colorado) announced today the completion of product development work and the launch of several important sterile compounded medications that are widely used in pediatric hospitals.
According to US researchers, data on drugs that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines hit the market. They released a study this Tuesday in Journal of the American Medical Association which found nearly a third of new drug approvals from the Food and Drug Administration included no data on how well the medications compare with existing alternatives.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey David Crawford, MD Po Box 1189, Corvallis, OR 97339-1189 Ph: () - | Dr Jeffrey David Crawford, MD 3615 Nw Samaritan Dr Ste 201, Corvallis, OR 97330-3771 Ph: (541) 768-5930 |
News Archive
A growing cadre of specialists - geriatric oncologists - is the latest group of medical pioneers to meet the challenge of a rising cancer incidence among older adults. They are investigating how to fill the gaps in the way oncology is practiced today, which sometimes neglects the special needs of the elderly.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announced today that it conducted its first clinical Investigators Meeting for Oregovomab in Rome, Italy.
The world is bracing for the impact of the novel coronavirus, COVID-19, which has now spread to over 30 countries, infecting more than 80,000 people with over 2,600 deaths globally. A better understanding of how this virus is transmitted is key to preventing its spread.
STAQ (Safety, Transparency, Availability, Quality) Pharma and Children's Hospital Colorado (Children's Colorado) announced today the completion of product development work and the launch of several important sterile compounded medications that are widely used in pediatric hospitals.
According to US researchers, data on drugs that could save money and help doctors make smarter treatment decisions are often unavailable at the time new medicines hit the market. They released a study this Tuesday in Journal of the American Medical Association which found nearly a third of new drug approvals from the Food and Drug Administration included no data on how well the medications compare with existing alternatives.
› Verified 6 days ago
Mrs. Ashley Hennessey Mcmann, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-5111 | |
Dr. Yarrow J. Mcconnell, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 441 Nw Elks Dr Ste 101, Corvallis, OR 97330 Phone: 541-768-1252 | |
Spencer Larson Hill, DO Surgery Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-4906 | |
Russell W Hyde, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-5111 | |
Adena Zadourian, DO Surgery Medicare: Medicare Enrolled Practice Location: 3600 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-768-5111 | |
Peter C Hudson, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 3680 Nw Samaritan Dr, Corvallis, OR 97330 Phone: 541-754-1150 |